229 related articles for article (PubMed ID: 28931195)
21. Free-flap reconstruction for the management of life-threatening hereditary hemorrhagic telangiectasia.
Choi JW; Joo YH; Jeong WS; Jang YJ
Auris Nasus Larynx; 2017 Oct; 44(5):607-611. PubMed ID: 27616747
[TBL] [Abstract][Full Text] [Related]
22. Neodymium-YAG laser intranasal photocoagulation in hereditary hemorrhagic telangiectasia: an update report.
Kluger PB; Shapshay SM; Hybels RL; Bohigian RK
Laryngoscope; 1987 Dec; 97(12):1397-401. PubMed ID: 3683050
[TBL] [Abstract][Full Text] [Related]
23. An evaluation of the severity and progression of epistaxis in hereditary hemorrhagic telangiectasia 1 versus hereditary hemorrhagic telangiectasia 2.
Hunter BN; Timmins BH; McDonald J; Whitehead KJ; Ward PD; Wilson KF
Laryngoscope; 2016 Apr; 126(4):786-90. PubMed ID: 26372311
[TBL] [Abstract][Full Text] [Related]
24. Control of epistaxis in patients with hereditary hemorrhagic telangiectasia.
Siegel MB; Keane WM; Atkins JF; Rosen MR
Otolaryngol Head Neck Surg; 1991 Nov; 105(5):675-9. PubMed ID: 1754250
[TBL] [Abstract][Full Text] [Related]
25. Influence of temporary nasal occlusion (tNO) on epistaxis frequency in patients with hereditary hemorrhagic telangiectasia (HHT).
Wirsching KEC; Haubner F; Kühnel TS
Eur Arch Otorhinolaryngol; 2017 Apr; 274(4):1891-1896. PubMed ID: 28070641
[TBL] [Abstract][Full Text] [Related]
26. Nasal closure for the treatment of epistaxis secondary to hereditary hemorrhagic telangiectasia.
Sena Esteves S; Cardoso C; Silva A; Abrunhosa J; Almeida E Sousa C
Acta Otorrinolaringol Esp; 2016; 67(6):345-348. PubMed ID: 27079134
[TBL] [Abstract][Full Text] [Related]
27. Argon plasma coagulation is an effective treatment for hereditary hemorrhagic telangiectasia patients with severe nosebleeds.
Pagella F; Matti E; Chu F; Pusateri A; Tinelli C; Olivieri C; Canzonieri C; Boeri L; Ornati F; Danesino C
Acta Otolaryngol; 2013 Feb; 133(2):174-80. PubMed ID: 23066781
[TBL] [Abstract][Full Text] [Related]
28. Efficiency of laser treatment in patients with hereditary hemorrhagic telangiectasia.
Jørgensen G; Lange B; Wanscher JH; Kjeldsen AD
Eur Arch Otorhinolaryngol; 2011 Dec; 268(12):1765-70. PubMed ID: 21706320
[TBL] [Abstract][Full Text] [Related]
29. The utility of bipolar electrocautery in hereditary hemorrhagic telangiectasia.
Ghaheri BA; Fong KJ; Hwang PH
Otolaryngol Head Neck Surg; 2006 Jun; 134(6):1006-9. PubMed ID: 16730547
[TBL] [Abstract][Full Text] [Related]
30. Sclerotherapy for Hereditary Hemorrhagic Telangiectasia-Related Epistaxis: A Systematic Review.
Thiele B; Abdel-Aty Y; Marks L; Lal D; Marino M
Ann Otol Rhinol Laryngol; 2023 Jan; 132(1):82-90. PubMed ID: 35152768
[TBL] [Abstract][Full Text] [Related]
31. A treatment algorithm for the management of epistaxis in hereditary hemorrhagic telangiectasia.
Lund VJ; Howard DJ
Am J Rhinol; 1999; 13(4):319-22. PubMed ID: 10485021
[TBL] [Abstract][Full Text] [Related]
32. Intranasal topical estrogen in the management of epistaxis in hereditary hemorrhagic telangiectasia.
Minami K; Haji T
Acta Otolaryngol; 2016; 136(5):528-31. PubMed ID: 26808464
[TBL] [Abstract][Full Text] [Related]
33. [Bevacizumab: a new success in hereditary hemorrhagic telangiectasia].
Bennesser Alaoui H; Lehraiki M; Hamaz S; El Attar N; Fakhreddine N; Serraj K
Rev Med Interne; 2015 Sep; 36(9):623-5. PubMed ID: 25595875
[TBL] [Abstract][Full Text] [Related]
34. Nd-YAG laser photocoagulation for epistaxis associated with hereditary hemorrhagic telangiectasia.
Mahoney EJ; Shapshay SM
Laryngoscope; 2005 Feb; 115(2):373-5. PubMed ID: 15689770
[No Abstract] [Full Text] [Related]
35. Effect of Topical Intranasal Therapy on Epistaxis Frequency in Patients With Hereditary Hemorrhagic Telangiectasia: A Randomized Clinical Trial.
Whitehead KJ; Sautter NB; McWilliams JP; Chakinala MM; Merlo CA; Johnson MH; James M; Everett EM; Clancy MS; Faughnan ME; Oh SP; Olitsky SE; Pyeritz RE; Gossage JR
JAMA; 2016 Sep; 316(9):943-51. PubMed ID: 27599329
[TBL] [Abstract][Full Text] [Related]
36. Duration of effectiveness of coblation for recurrent epistaxis in hereditary hemorrhagic telangiectasia.
Feller CN; Adams JA; Friedland DR; Poetker DM
Am J Otolaryngol; 2022; 43(3):103409. PubMed ID: 35216850
[TBL] [Abstract][Full Text] [Related]
37. Use of a sprayed fibrin hemostatic sealant after laser therapy for hereditary hemorrhagic telangiectasia epistaxis.
Richmon JD; Tian Y; Husseman J; Davidson TM
Am J Rhinol; 2007; 21(2):187-91. PubMed ID: 17424877
[TBL] [Abstract][Full Text] [Related]
38. Treatment of epistaxis in hereditary hemorrhagic telangiectasia patients by argon plasma coagulation with local anesthesia.
Pagella F; Semino L; Olivieri C; Corno S; Dore R; Draghi F; Lanzarini L; Vespro V; Buscarini E; Danesino C
Am J Rhinol; 2006; 20(4):421-5. PubMed ID: 16955772
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of intranasal Bevacizumab (Avastin) treatment in patients with hereditary hemorrhagic telangiectasia-associated epistaxis.
Karnezis TT; Davidson TM
Laryngoscope; 2011 Mar; 121(3):636-8. PubMed ID: 21344445
[TBL] [Abstract][Full Text] [Related]
40. Sclerotherapy Versus Cautery/Laser Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia.
Woodard TD; Yappel-Sinkko KB; Wang X; McCrae KR; Parambil JG
Laryngoscope; 2022 May; 132(5):920-925. PubMed ID: 34160081
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
